177 related articles for article (PubMed ID: 3771751)
1. Staphylococcal resistance to aminoglycosides before and after introduction of amikacin in two teaching hospitals.
Hammerberg O; Elder D; Richardson H; Landis S
J Clin Microbiol; 1986 Oct; 24(4):629-32. PubMed ID: 3771751
[TBL] [Abstract][Full Text] [Related]
2. Resistance of gram-negative bacilli and staphylococci from blood cultures to aminoglycoside antibiotics. Comparison of 3 in vitro investigations from Austria 1982-1988.
Mittermayer H; Rotter M; Breitfellner G; Riezinger F; Thiel W; Binder L; Watschinger R
Zentralbl Bakteriol; 1990 Apr; 272(4):448-57. PubMed ID: 2113808
[TBL] [Abstract][Full Text] [Related]
3. Development of resistance to aminoglycosides among coagulase-negative staphylococci and enterobacteriaceae in a neonatal intensive care unit.
Krediet TG; Fleer A; Gerards LJ
J Hosp Infect; 1993 May; 24(1):39-46. PubMed ID: 8101201
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
[TBL] [Abstract][Full Text] [Related]
5. In vitro interaction between cefotetan and aminoglycosides on Staphylococcus aureus and coagulase negative staphylococci, both methicillin-susceptible and -resistant.
Stefani S; Debbia E; Schito GC; Nicoletti G
Chemioterapia; 1988 Jun; 7(3):151-5. PubMed ID: 3168069
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative staphylococci from a single neonatal intensive care unit, 1989-2000.
Klingenberg C; Sundsfjord A; Rønnestad A; Mikalsen J; Gaustad P; Flaegstad T
J Antimicrob Chemother; 2004 Nov; 54(5):889-96. PubMed ID: 15471996
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside resistance among blood culture isolates.
Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
[TBL] [Abstract][Full Text] [Related]
8. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
13. [Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?].
Hernández ME; Ramos MJ; Ferrer NF
Rev Panam Salud Publica; 2004 Nov; 16(5):315-9. PubMed ID: 15729980
[TBL] [Abstract][Full Text] [Related]
14. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
15. Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance.
Huovinen P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):153-7. PubMed ID: 3739715
[TBL] [Abstract][Full Text] [Related]
16. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect of aminoglycosides on staphylococci.
Isaksson B; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococci.
Busch-Sørensen C; Frimodt-Møller N; Miller GH; Espersen F
APMIS; 1996 Dec; 104(12):873-80. PubMed ID: 9048865
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
